alithea

Logo Schwarz PRODUCTS APPLICATIONS
ABOUT US
PRODUCTS APPLICATIONS
ABOUT US

intro LAB AUTOMATION intro Machine learning for data
analysis automation
intro High throughput proteomics
THE PRECISION IMMUNOTHERAPY COMPANY keyboard_arrow_right keyboard_arrow_right

intro Alithea’s technology:
ZOOMASS™
info Alithea’s technology ZOOMASS™ applies highly sensitive mass spectrometry to profile HLA-presented epitopes, the targets of T cells. Its specific focus is epitopes from specific genetic regions of interest. info2 The ZOOMASS™ technology distinguishes Alithea from competitor technology which typically apply standard proteomics methods that lack sensitivity if you are looking for specific antigens only.

ZOOMASS™ allows looking for tens of thousands of epitopes of interest, which was not possible before the development of ZOOMASS™.
info2b Based on ZOOMASS™, Alithea has developed specific assays for:
- detecting neoepitopes on tumour cells with unprecedented sensitivity (NEOZOOM™) and for
- detecting epitopes from the specific genetic element of the question (CONZOOM™)
keyboard_arrow_right keyboard_arrow_right

Logo Schwarz We develop precision medicine strategies